MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Aging"

  • 2025 International Congress

    End-of-life care management in Parkinson’s disease: a national survey of caregivers’s own experiences and perceptions

    A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

    Objective: To describe the personal experiences and perceptions of caregivers of people diagnosed with Parkinson's disease (PD) who are either in the advanced stages of…
  • 2025 International Congress

    End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

    A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

    Objective: To describe the personal experiences and perceptions of healthcare practitioners (HCP) involved in the terminal management of people diagnosed with Parkinson's disease (PD) Background:…
  • 2025 International Congress

    Artificial Intelligence for Understanding Parkinson Disease State and Patient Stratification Using CSF Proteomics

    L. Abu Zohair, H. Zantout, M. Vallejo, M. Uddin (Edinburgh, United Kingdom)

    Objective: The objective of this research is to employ an Artificial Intelligence (AI) approaches to identify patient status and disease states in neurodegenerative diseases (NDDs),…
  • 2025 International Congress

    Safety Profile of Opicapone in Elderly and Very Elderly Population

    D. Lopes, I. Peixoto, D. Martins, H. Brigas, H. Gama, J. Holenz (Coronado, Portugal)

    Objective: This study aimed to characterize the safety profile of opicapone (OPC) in the elderly and compare post-marketing safety between (A) very elderly patients (≥…
  • 2025 International Congress

    Epigenome-wide and gene-targeted epigenetic profile of isolated REM Sleep Behaviour Disorder: a clinico-molecular study

    L. Baldelli, C. Pirazzini, L. Sambati, F. Ravaioli, F. Di Laudo, D. Gentilini, P. Guaraldi, C. Franceschi, P. Cortelli, P. Garagnani, G. Calandra-Buonaura, MG. Bacalini, F. Provini (Bologna, Italy)

    Objective: Comprehensively characterize the epigenetic profile of isolated REM Sleep Behaviour Disorder (iRBD) using genome-wide and gene-targeted approaches, linking it to clinical measures and  phenoconversion.…
  • 2025 International Congress

    Role of APOE Polymorphism and CSF Markers of AD Co-Pathology in the Cognitive Trajectories of Sporadic and Genetic Parkinson’s Disease: A Longitudinal Cohort Study

    R. Botta, J. Locascio, R. Ye, A. Goodheart, S. Gomperts (Boston, USA)

    Objective: To evaluate if APOE genotype and CSF biomarkers of AD co-pathology are associated with distinct rates of cognitive decline in PD subtypes. Background: Cognitive…
  • 2025 International Congress

    Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

    M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)

    Objective: We compared the clinical symptoms of early Parkinson's disease (PD) between young-onset and elderly-onset. Background: The progression of PD varies depending on the age…
  • 2025 International Congress

    Epidemiology of Parkinson’s disease in Southern Brazil: Age- and Sex-Specific Findings from the PROBE-PD Study

    G. Pereira, N. Soares, C. Sangali, D. Teixeira-Dos-Santos, G. Valença, B. Lopes, P. Brandão, C. Rieder, A. Schuh (Porto Alegre, Brazil)

    Objective: To examine the prevalence of Parkinson’s disease and parkinsonism in individuals aged 60 years and older in a population-based sample from Southern Brazil, analyzing…
  • 2025 International Congress

    Planning for the Parkinson’s Pandemic: Care needs in Australian Residential Aged Care Facilities

    J. Mcginley, S. Soh, Y. Mok, M. Callisaya, V. Mcconvey, M. Klaic, A. Vogel, D. Koye, D. Finkelstein, K. Bower (Parkville, Australia)

    Objective: To evaluate the prevalence, demographic characteristics and care needs of people with Parkinson’s disease (PD) living permanently in residential aged care facilities (RACF) in…
  • 2025 International Congress

    Ecologically Valid, Ambient, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Parkinson’s Disease (EVALUATE-PD)

    J. Kaye, E. Leonard, L. Talman, N. Rodrigues, Z. Beattie (Portland, USA)

    Objective: To determine the feasibility of using in-home digital biomarkers (DBs) and activity monitoring for clinical trials and studies of early Parkinson’s Disease (PD) and…
  • 1
  • 2
  • 3
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley